Investing

Top Analyst Downgrades, Stocks to Sell: Apple, Twitter, First Solar and More

It is the first full trading week of 2014, and investors are trying to decide how to position their portfolios for the year. Wall Street brokerage firms are making their 2014 predictions almost daily now, and the stock market is effectively at all-time highs. 24/7 Wall St. reviews many fresh research calls each and every morning on the hunt for new ideas, and we have broken out the negative analyst calls today. These are this Monday’s top analyst downgrades and cautious research notes from Wall Street.

Apple Inc. (NASDAQ: AAPL) was downgraded to Sell from an already cautious Hold rating at a boutique firm called Standpoint Research. The reason for this downgrade seems to be based more on moral reasons rather than fundamental ones, although these can overlap if sentiment and media move against a company. Apple shares were down 2% on Friday, and shares were indicated marginally lower on Monday after this call.

Twitter Inc. (NYSE: TWTR) has taken yet another downgrade, this one coming from Morgan Stanley. The firm dropped the micro-blogging leader down to Underweight from an already cautious Equal Weight. Effectively, this is a Sell rating. The price target is down at $33 per share, versus a $69.00 closing bell price. Shares were indicated down another 3% on Monday. Maybe having a valuation at 60 times revenues is still just too much.

First Solar Inc. (NASDAQ: FSLR) was downgraded to Sell from Buy at Goldman Sachs, and shares were indicated down almost 5%, after the firm went to favoring the service side of the solar equation rather than the panel side.

Other key analyst downgrades were seen in the following stocks:

AFLAC Inc. (NYSE: AFL) was downgraded to Neutral from Outperform at Credit Suisse.

Alexion Pharmaceuticals Inc. (NASDAQ: ALXN) was downgraded to Neutral from Buy at Goldman Sachs.

ARIAD Pharmaceuticals Inc. (NASDAQ: ARIA) was downgraded to Sell from Neutral at Citigroup.

Arris Enterprises Inc. (NASDAQ: ARRS) was downgraded to Equal Weight from Overweight at Barclays.

Celgene Corp. (NASDAQ: CELG) was downgraded to Sell from Neutral at Goldman Sachs.

eBay Inc. (NASDAQ: EBAY) was downgraded to Equal Weight from Overweight at Morgan Stanley.

Sanofi (NYSE: SNY) was downgraded to Neutral from Overweight at J.P. Morgan.

Wendy’s Co. (NASDAQ: WEN) was downgraded to Neutral from Buy at Janney Capital Markets.

WEX Inc. (NYSE: WEX) was downgraded to Underperform from Neutral based on an unfavorable risk/reward profile with a $90 price target (versus a $97.10 close) at Sterne Agee.

Take Charge of Your Retirement In Just A Few Minutes (Sponsor)

Retirement planning doesn’t have to feel overwhelming. The key is finding expert guidance—and SmartAsset’s simple quiz makes it easier than ever for you to connect with a vetted financial advisor.

Here’s how it works:

  1. Answer a Few Simple Questions. Tell us a bit about your goals and preferences—it only takes a few minutes!
  2. Get Matched with Vetted Advisors Our smart tool matches you with up to three pre-screened, vetted advisors who serve your area and are held to a fiduciary standard to act in your best interests. Click here to begin
  3. Choose Your  Fit Review their profiles, schedule an introductory call (or meet in person), and select the advisor who feel is right for you.

Why wait? Start building the retirement you’ve always dreamed of. Click here to get started today!

 

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.

AI Portfolio

Discover Our Top AI Stocks

Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.

You can follow him investing $500,000 of his own money on our top AI stocks for free.